Foamy virus vectors.
Gene therapy is a promising novel treatment for a variety of human diseases. Successful application of gene therapy requires the availability of vehicles with the ability to efficiently deliver and express genes. Viral vectors are efficient means of transferring a gene of interest into target cells. Current available vehicles for gene transfer are either inefficient or potentially unsafe for human gene therapy applications. Foamy viruses offer a fresh alternative vector system for gene transfer with the potential to overcome the concerns of the current vectors. Foamy viruses are nonpathogenic and have a broad host range with the ability to infect various types of cells from different species. Foamy virus replication is distinct and may provide an edge for foamy virus vector usage over other retroviral vectors. These features offer the foamy vectors unique opportunities to deliver several genes into a number of different cell types in vivo safely and efficiently. The principal problems for the design of foamy virus vectors have been solved, and several foamy virus vectors that efficiently transduce a variety of cell types are available. This chapter reviews specific features of foamy virus vector systems and recent advances in the development and use of these vectors.
Mergia
A
A
Department of Pathobiology, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA. Mergiaa@mail.vetmed.ufl.edu
Heinkelein
M
M
D000818:Animals; D003550:Cystic Fibrosis / Q000628:therapy; D018014:Gene Transfer Techniques; D015751:Genes, pol; D015316:Genetic Therapy / Q000009:adverse effects / Q000379:methods; D005822:Genetic Vectors / Q000737:chemistry / Q000235:genetics; D006801:Humans; D008957:Models, Genetic; D012045:Regulatory Sequences, Nucleic Acid; D016092:Spumavirus / Q000235:genetics* / Q000254:growth & development / Q000502:physiology; D014018:Tissue Distribution; D014158:Transcription, Genetic; D019076:Transgenes; D014779:Virus Replication